Harel is a seasoned executive and entrepreneur in the healthcare space, where he has an extensive and proven track record of over 15 years of leadership in the corporate world as well as the start-up sector, including positions in the USA, Europe and Israel.
In 2010, Harel founded MEDX Ventures Group LLC, an investment and management firm with offices in the USA, Europe and Israel. Harel founded and serves as the CEO & Chairman of Microbot Medical Ltd., a promising early stage medical device company. In addition, Harel founded and serves as the Chairman of XACT Robotics™ Ltd., another transformational, early stage medical device company, where MEDX is the leading investor. Until 2013, Harel also served on the board of directors at ConTIPI Ltd., which was acquired in 2012 by a leading multinational corporation.
Until 2010, Harel served as a Worldwide Group Marketing Director at Johnson & Johnson (Ethicon Inc., Somerville NJ), overseeing the company’s global strategic marketing. Prior to this, Harel was the Regional Marketing Manager at Johnson & Johnson (Ethicon Inc.), responsible for the strategic marketing for Europe, Middle East and Africa. During his tenure, Harel led both companies to continuous growth in revenues and new product launches (both from internal R&D and M&A). Harel also held several management positions in marketing and sales at Johnson & Johnson Medical Israel.
Harel is a guest speaker for management and innovation courses at leading universities in the USA and Israel, including the Technion – Israel Institute of Technology. Harel holds a Bachelor of Science (BS) from Siena College (USA) and a Master in Business Administration (MBA) from Manchester University (UK).
If you are interested in learning more about TIGER 21, please complete the contact form and you will receive a copy of our most recent Asset Allocation Report.